Fecal transplant
Sponsors
University Health Network, Toronto, Hamilton Health Sciences Corporation, Jasmohan Bajaj, Sture Andersson, Tel-Aviv Sourasky Medical Center
Conditions
Alopecia AreataCirrhosisHepatic EncephalopathyIntestinal MicrobiomeLaboratory Confirmed Clostridium Difficile InfectionRecurrent Clostridium Difficile InfectionUlcerative Colitisinsulin resistance
metabolic syndrome
Phase 1
Phase 2
Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin
TerminatedNCT01226992
Start: 2010-10-31End: 2014-10-31Updated: 2014-12-08
Fecal Biotherapy for the Induction of Remission in Active Ulcerative Colitis
CompletedNCT01545908
Start: 2012-03-31End: 2014-08-31Target: 130Updated: 2015-03-19
Unknown Phase
Fecal microbiota tRAnspLantation uSed TO improve postpraNdial bacterIAl translocation;
the RALSTONIA study.
Active, not recruitingNL-OMON47262
Start: 2015-12-28Target: 36Updated: 2024-02-28
Cesarean Section and Intestinal Flora of the Newborn
CompletedNCT03568734
Start: 2017-10-27End: 2018-12-31Updated: 2019-02-11
Fecal Transplant for Alopecia Areata
NCT04833179
Start: 2021-05-31End: 2025-04-30Target: 110Updated: 2021-04-06